GREAT BASIN SCIENTIFIC, INC. (NASDAQ:GBSN) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition.
On Janaury 24, 2017, Great Basin Scientific Inc. (the Company)
issued a press release announcingits revenuesand customer results
for the quarter and calendar year ended December 31, 2016. A copy
of this press release is furnished as Exhibit 99.1 to this
Current Report on Form 8-K and isincorporated by reference
herein.
In accordance with General Instruction B.2 of Form 8-K, the
information in this Item, including the exhibit attached hereto,
shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
nor shall such information be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, or
theExchange Act, except as shall be expressly set forth by
specific reference in such a filing.
Item 7.01 Regulation FD Disclosure.
On January 24, 2017, the Company issued a press release
announcingits revenue and customer results for the quarter and
calendar year ended December 31, 2016. A copy of this press
release is furnished as Exhibit 99.1 to this Current Report on
Form 8-K and is incorporated by reference herein.
In accordance with General Instruction B.2 of Form 8-K, the
information in this Item, including the exhibits attached hereto,
shall not be deemed filed for purposes of Section 18 of
theSecurities Exchange Act of 1934, as amended (the Exchange
Act), nor shall such information be deemed incorporated by
reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set
forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
| Exhibit No. | Description | |
| 99.1* | Press Release dated January 24, 2017. |
* The Exhibit relating to Items 2.02 and 7.01 areintended to be
furnished to, not filed with, the SEC to Regulation FD
About GREAT BASIN SCIENTIFIC, INC. (NASDAQ:GBSN)
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals. GREAT BASIN SCIENTIFIC, INC. (NASDAQ:GBSN) Recent Trading Information
GREAT BASIN SCIENTIFIC, INC. (NASDAQ:GBSN) closed its last trading session 00.0000 at 0.0602 with 6,203 shares trading hands.
